Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.05
DYNT's Cash to Debt is ranked lower than
97% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. DYNT: 0.05 )
Ranked among companies with meaningful Cash to Debt only.
DYNT' s 10-Year Cash to Debt Range
Min: 0.01  Med: 0.07 Max: 0.52
Current: 0.05
0.01
0.52
Equity to Asset 0.32
DYNT's Equity to Asset is ranked lower than
86% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. DYNT: 0.32 )
Ranked among companies with meaningful Equity to Asset only.
DYNT' s 10-Year Equity to Asset Range
Min: 0.32  Med: 0.52 Max: 0.71
Current: 0.32
0.32
0.71
F-Score: 3
Z-Score: 2.06
M-Score: -1.86
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -1.09
DYNT's Operating margin (%) is ranked lower than
56% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 3.07 vs. DYNT: -1.09 )
Ranked among companies with meaningful Operating margin (%) only.
DYNT' s 10-Year Operating margin (%) Range
Min: -28.6  Med: 2.94 Max: 9.38
Current: -1.09
-28.6
9.38
Net-margin (%) -1.23
DYNT's Net-margin (%) is ranked lower than
54% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 1.62 vs. DYNT: -1.23 )
Ranked among companies with meaningful Net-margin (%) only.
DYNT' s 10-Year Net-margin (%) Range
Min: -25.91  Med: 0.83 Max: 5.88
Current: -1.23
-25.91
5.88
ROE (%) -5.82
DYNT's ROE (%) is ranked lower than
60% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 3.09 vs. DYNT: -5.82 )
Ranked among companies with meaningful ROE (%) only.
DYNT' s 10-Year ROE (%) Range
Min: -97.41  Med: 3.03 Max: 13.08
Current: -5.82
-97.41
13.08
ROA (%) -2.10
DYNT's ROA (%) is ranked lower than
53% of the 322 Companies
in the Global Medical Devices industry.

( Industry Median: -0.62 vs. DYNT: -2.10 )
Ranked among companies with meaningful ROA (%) only.
DYNT' s 10-Year ROA (%) Range
Min: -45.65  Med: 1.60 Max: 6.63
Current: -2.1
-45.65
6.63
ROC (Joel Greenblatt) (%) -2.65
DYNT's ROC (Joel Greenblatt) (%) is ranked lower than
54% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 3.55 vs. DYNT: -2.65 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
DYNT' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -75.98  Med: 6.17 Max: 37.93
Current: -2.65
-75.98
37.93
Revenue Growth (3Y)(%) -3.80
DYNT's Revenue Growth (3Y)(%) is ranked lower than
69% of the 201 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. DYNT: -3.80 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
DYNT' s 10-Year Revenue Growth (3Y)(%) Range
Min: -3.8  Med: 3.45 Max: 37.6
Current: -3.8
-3.8
37.6
EBITDA Growth (3Y)(%) -27.20
DYNT's EBITDA Growth (3Y)(%) is ranked lower than
85% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 4.00 vs. DYNT: -27.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
DYNT' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0  Med: -13.60 Max: 47.9
Current: -27.2
0
47.9
» DYNT's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with DYNT

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 1.30
DYNT's P/B is ranked higher than
83% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 3.03 vs. DYNT: 1.30 )
Ranked among companies with meaningful P/B only.
DYNT' s 10-Year P/B Range
Min: 0.54  Med: 1.41 Max: 3.76
Current: 1.3
0.54
3.76
P/S 0.27
DYNT's P/S is ranked higher than
98% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 2.77 vs. DYNT: 0.27 )
Ranked among companies with meaningful P/S only.
DYNT' s 10-Year P/S Range
Min: 0.11  Med: 0.35 Max: 1.19
Current: 0.27
0.11
1.19
Shiller P/E 181.26
DYNT's Shiller P/E is ranked lower than
94% of the 96 Companies
in the Global Medical Devices industry.

( Industry Median: 30.83 vs. DYNT: 181.26 )
Ranked among companies with meaningful Shiller P/E only.
DYNT' s 10-Year Shiller P/E Range
Min: 19.07  Med: 32.41 Max: 181.26
Current: 181.26
19.07
181.26
Current Ratio 1.74
DYNT's Current Ratio is ranked lower than
70% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 2.42 vs. DYNT: 1.74 )
Ranked among companies with meaningful Current Ratio only.
DYNT' s 10-Year Current Ratio Range
Min: 1.43  Med: 2.20 Max: 7.8
Current: 1.74
1.43
7.8
Quick Ratio 0.72
DYNT's Quick Ratio is ranked lower than
88% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. DYNT: 0.72 )
Ranked among companies with meaningful Quick Ratio only.
DYNT' s 10-Year Quick Ratio Range
Min: 0.59  Med: 1.07 Max: 4.5
Current: 0.72
0.59
4.5
Days Inventory 120.27
DYNT's Days Inventory is ranked higher than
56% of the 282 Companies
in the Global Medical Devices industry.

( Industry Median: 130.22 vs. DYNT: 120.27 )
Ranked among companies with meaningful Days Inventory only.
DYNT' s 10-Year Days Inventory Range
Min: 103.09  Med: 134.56 Max: 175.22
Current: 120.27
103.09
175.22
Days Sales Outstanding 36.84
DYNT's Days Sales Outstanding is ranked higher than
90% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 69.40 vs. DYNT: 36.84 )
Ranked among companies with meaningful Days Sales Outstanding only.
DYNT' s 10-Year Days Sales Outstanding Range
Min: 40.12  Med: 57.68 Max: 91.25
Current: 36.84
40.12
91.25

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 1.36
DYNT's Price/Tangible Book is ranked higher than
88% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 4.09 vs. DYNT: 1.36 )
Ranked among companies with meaningful Price/Tangible Book only.
DYNT' s 10-Year Price/Tangible Book Range
Min: 0.75  Med: 1.71 Max: 6.4
Current: 1.36
0.75
6.4
Price/Projected FCF 0.69
DYNT's Price/Projected FCF is ranked higher than
92% of the 114 Companies
in the Global Medical Devices industry.

( Industry Median: 2.05 vs. DYNT: 0.69 )
Ranked among companies with meaningful Price/Projected FCF only.
DYNT' s 10-Year Price/Projected FCF Range
Min: 0.58  Med: 1.31 Max: 13.15
Current: 0.69
0.58
13.15
Price/Median PS Value 0.76
DYNT's Price/Median PS Value is ranked higher than
75% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 1.06 vs. DYNT: 0.76 )
Ranked among companies with meaningful Price/Median PS Value only.
DYNT' s 10-Year Price/Median PS Value Range
Min: 0.37  Med: 1.56 Max: 7.5
Current: 0.76
0.37
7.5
Earnings Yield (Greenblatt) (%) -2.16
DYNT's Earnings Yield (Greenblatt) (%) is ranked lower than
57% of the 311 Companies
in the Global Medical Devices industry.

( Industry Median: 0.40 vs. DYNT: -2.16 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
DYNT' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: -2.21  Med: 3.50 Max: 9.5
Current: -2.16
-2.21
9.5
Forward Rate of Return (Yacktman) (%) -18.99
DYNT's Forward Rate of Return (Yacktman) (%) is ranked lower than
91% of the 110 Companies
in the Global Medical Devices industry.

( Industry Median: 4.59 vs. DYNT: -18.99 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
DYNT' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -25.3  Med: 0.10 Max: 16.5
Current: -18.99
-25.3
16.5

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Dynatronics Corp is a Utah corporation formed on April 29, 1983. The Company manufactures and distributes medical equipment including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used mainly by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals. The products it manufactures falls into two categories: Physical Medicine Products and Aesthetic Products. Its Physical Medicine Products include: Electrotherapy, Therapeutic Ultrasound, Phototherapy, Thermal Therapy, Oscillation Therapy, Iontophoresis, Manufactured Medical Supplies and Soft Goods, and Manufactured Treatment Tables and Rehabilitation Equipment. The Company manufactures and markets aesthetic products under the brand name of Synergie. The Synergie Elite Aesthetic Massage System applies therapeutic vacuum massage to skin and subcutaneous tissues to achieve a temporary reduction in the appearance of cellulite and reduces the circumferential body measurements of the treated areas. It also manufactures and markets the Synergie Elite microdermabrasion device as a companion to the AMS device. The icrodermabrasion device gently exfoliates the upper layers of skin, exposing softer, smoother skin. In conjunction with the microdermabrasion devices, it offers a unique line of skin care products under the trademark Calisse which is designed to enhance the effects of the icrodermabrasion treatments. As part of the aesthetics line of products, it markets the Synergie Elite LT device which provides phototherapy for aesthetic pplications. Phototherapy is used in aesthetic applications to improve skin tone and appearance. Combining elements of the AMS vacuum massage techniques with microdermabrasion and Synergie Elite LT for phototherapy has provided aestheticians with the ability to provide an enhanced 'ultimate facial' available only with the use of Synergie devices. The Company's trademarks include 'Dynatron', 'Dynatron Solaris,' 'Synergie,' 'Synergie Peel,' 'Dynaheat,' 'BodyIce, and 'Nutura'. The Company sells its products mainly to licensed practitioners such as physical therapists, chiropractors, podiatrists, sports medicine specialists, medical doctors, hospitals and clinics, plastic surgeons, dermatologists and aestheticians. It has 52 direct sales representatives. Its competitors that manufactures clinical electrotherapy and ultrasound equipment include DJO (Chattanooga Brand), Rich-Mar, Mettler Electronics and the Metron Division of Patterson Medical. Its competitors in the iontophoresis market include DJO (EMPI and Iomed divisions) Rich-Mar, Travanti Pharma and ActivaTek Inc. The Company's main competition in the treatment table market is from domestic manufacturers including Hill Laboratories Company, Hausmann Industries, Patterson Medical, Bailey Manufacturing, Tri-W-G, DJO, Armedica, and Clinton Industries. Its competitor in the
» More Articles for DYNT

Headlines

Articles On GuruFocus.com
physical therepy eqi Jan 09 2013 
Dynatronics Corp. Reports Operating Results (10-Q) Nov 12 2010 
Dynatronics Corp. Reports Operating Results (10-Q) May 17 2010 
Dynatronics Corp. Reports Operating Results (10-Q) Feb 01 2010 
Dynatronics Corp. Reports Operating Results (10-Q/A) Aug 27 2009 
Dynatronics Corp. Reports Operating Results (10-K/A) Aug 27 2009 
Dynatronics Corp. Reports Operating Results (10-Q/A) Aug 26 2009 
Dynatronics Corp. Reports Operating Results (10-Q/A) Aug 26 2009 
Dynatronics Corp. Reports Operating Results (10-Q) May 14 2009 
Dynatronics Corp. Reports Operating Results (10-Q) Feb 14 2009 

More From Other Websites
Dynatronics Announces Patent Approval for ThermoStim Probe Aug 17 2015
Dynatronics Gains Approval of its ThermoStim Probe Patent Aug 12 2015
Dynatronics Announces CE Mark Approval on Solaris Jul 27 2015
Dynatronics Awarded CE Mark Approval for Its Solaris Products Jul 27 2015
DYNATRONICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to... Jul 22 2015
Dynatronics Announces the Appointment of New Board Members Jul 08 2015
Dynatronics Announces Appointment Of Erin Enright And Brian Larkin To Its Board Of Directors Jul 08 2015
DYNATRONICS CORP Financials Jul 01 2015
Dynatronics Announces Completion of $4,025,000 Private Placement Led by Prettybrook Partners Jul 01 2015
Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners Jul 01 2015
Dynatronics Announces Fiscal 2015 Third Quarter Results May 15 2015
Dynatronics Announces Fiscal Third Quarter Financial Results May 14 2015
Dynatronics To Release Fiscal Third Quarter Results Thursday, May 14, 2015; Conference Call set for... May 13 2015
Dynatronics to announce Fiscal 2015 Third Quarter Results May 13 2015
Dynatronics Announces $4,000,000 Private Placement Led by Prettybrook Partners May 04 2015
Dynatronics Announces $4,000,000 Private Placement Led By Prettybrook Partners May 04 2015
Dynatronics Announces the Appointment of Rich Linder to the Board of Directors Apr 03 2015
Dynatronics Announces Appointment of Richard J. Linder to Board of Directors Mar 27 2015
Dynatronics Announces Second Quarter Financial Results Feb 13 2015
Dynatronics To Release Fiscal Second Quarter Results Friday, February 13, 2015 Feb 12 2015
Dynatronics Announces Fiscal 2015 First Quarter Results Nov 14 2014
Dynatronics Announces Promising First Quarter Financial Results Nov 14 2014
Dynatronics to Announces Fiscal 2015 First Quarter Results Nov 13 2014
Dynatronics Announces the Passing of Joe Barton, a member of the Board of Directors Nov 13 2014
Dynatronics To Release Fiscal First Quarter Results Friday, November 14, 2014; Conference Call set... Nov 13 2014
Dynatronics Announces Passing of Board Member Joseph H. Barton Nov 12 2014
Dynatronics Fiscal Year 2014 Results Investor Conference Call Sep 29 2014
Dynatronics Announces Fourth Quarter and Year-end Financial Results Sep 29 2014
Dynatronics To Release Fiscal Year 2014 Results Sep 26 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK